High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP (HFDS_abinterno)
HFDS ab Interno - to Compare Intraocular Pressure (IOP) Lowering Effect of Combined High Frequency Deep Sclerotomy ab Interno (HFDS ab Interno) With Phacoemulsification and Phacoemulsification Alone, in Primary Open Angle Glaucoma Patients
Sponsor: Oertli Instrumente AG
A NA clinical study on Cataract and Glaucoma, this trial is ongoing. The trial is conducted by Oertli Instrumente AG and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Feb 2017 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oertli Instrumente AG
- University of Geneva, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .